Aurinia Pharmaceuticals Inc (LTS:0UJF)
C$ 15.41 0 (0%) Market Cap: 1.28 Bil Enterprise Value: 943.70 Mil PE Ratio: 0 PB Ratio: 2.56 GF Score: 78/100

Aurinia Pharmaceuticals Inc. - Special Call Transcript

Mar 26, 2020 / 09:15 PM GMT
Release Date Price: C$17.02


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AUPH.OQ - Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc. - Special Call
Mar 26, 2020 / 09:15PM GMT

=====================
Conference Call Participants
=====================
* Joseph Vassalotti;Nephrologist
* Keisha Gibson;University of North Carolina

=====================
Presentation
--------------------------------------------------------------------------------
Keisha Gibson;University of North Carolina, [1]
--------------------------------------------------------------------------------
(technical difficulty)

And thank you to the National Kidney Foundation and all of the sponsors of this meeting that worked so hard to make sure that we could join you virtually today.

I have the honor of representing the AURORA study group to present the results of our Phase III randomized trial, which assessed the superiority of voclosporin in combination with standard of care therapy over standard of care therapy alone in patients with active lupus nephritis.

These are my disclosures.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot